Triazolam
Triazolam, also known by the brand name Halcion, is a short-acting benzodiazepine medication primarily prescribed for the short-term treatment of insomnia. It works by enhancing the effect of a neurotransmitter called gamma-aminobutyric acid (GABA) in the brain, which leads to a calming and sedative effect. Triazolam is a Schedule IV controlled substance in the United States, indicating a potential for abuse and dependence.
The typical dosage of triazolam is very low, often in the range of 0.125 to 0.25 milligrams
Common side effects of triazolam can include drowsiness, dizziness, confusion, impaired coordination, and memory problems (amnesia).